Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

0.4450 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,027
Open 0.4450
Bid (Size) 0.4463 (45)
Ask (Size) 0.4500 (3)
Prev. Close 0.4450
Today's Range 0.4450 - 0.4450
52wk Range 0.3055 - 3.850
Shares Outstanding 279,140,015
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript
BNGO earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-77.75%
-77.75%
1 Month
+13.09%
+13.09%
3 Month
-47.29%
-47.29%
6 Month
-59.91%
-59.91%
1 Year
-87.25%
-87.25%

More News

Read More
3 Quantum AI Stocks That Could Redefine Computing
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Sorry Healthcare Stocks to Sell in May While You Still Can
Via InvestorPlace
The 3 Best Healthcare Stocks to Buy in May 2024
Via InvestorPlace
Earnings Outlook For Bionano Genomics
Via Benzinga
How Is The Market Feeling About Bionano Genomics?
Via Benzinga
Bionano Genomics: Q3 Earnings Insights
Via Benzinga
A Preview Of Bionano Genomics's Earnings
Via Benzinga
BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
3 Contrarian Investments to Make Now for Massive Upside Potential
Via InvestorPlace
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023
Via InvestorPlace
7 Penny Stocks to Buy on the Dip: February 2024
Via InvestorPlace
Earnings Scheduled For March 5, 2024
Via Benzinga
Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings
Via InvestorPlace
LeddarTech Appoints Chris Stewart as Chief Financial Officer
From LeddarTech inc.
Via GlobeNewswire
3 Stocks That Are Poised to Generate Outsized Returns
Via InvestorPlace
Bionano Genomics (BNGO) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
3 Deeply Undervalued Growth Stocks
Via InvestorPlace
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Via InvestorPlace
The 3 Best High-Risk, High-Reward Stocks to Buy Now: September 2023
Via InvestorPlace
7 F-Rated Meme Stocks to Avoid Like the Plague
Via InvestorPlace
These Are the ONLY 3 Meme Stocks to Consider in August 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.